Potent Synergistic Effect of Doxycycline with Fluconazole against Candida albicans Is Mediated by Interference with Iron Homeostasis
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Doxycycline was found to act synergistically with the antifungal fluconazole against Candida albicans . Combination with doxycycline converts fluconazole from fungistatic to fungicidal, prevents the onset of drug resistance, and is also effective against a clinical isolate characterized by elevated resistance to fluconazole. Investigation of the interactions between the two drugs by way of checkerboard assays indicated that doxycycline had an influence on the MIC for fluconazole, as defined by CLSI standards, only at high concentrations (200 μg/ml). However, lower concentrations were effective at eliminating residual cell growth at supra-MICs of fluconazole. Using MIC-0, defined as a drug combination resulting in optically clear wells, as an endpoint, doxycycline was found to be synergistic with fluconazole at a concentration as low as 25 μg/ml, with a fractional inhibitory concentration index of <0.5. Doxycycline-mediated growth inhibition can be reversed by externally added iron, indicating that iron depletion may account for the synergism. Consistently, we confirmed old literature data about iron-chelating activity of doxycycline. Synergism of fluconazole with doxycycline does not appear to be mediated by calcineurin, since doxycycline further aggravates the susceptibility to fluconazole of mutants lacking the catalytic or the regulatory subunits of calcineurin. Growth in the presence of fluconazole and doxycycline is restored by an elevated dosage of ERG11 in Saccharomyces cerevisiae but not in C. albicans , despite the full competence of the pathogen's protein to act as a suppressor in baker's yeast.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tolerance can be affected by several adjuvant drugs 12 , iron levels 26 , and genes involved in vacuolar protein sorting 19 , as well as calcium flux 14,27,28 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [26]
In the citing paper
“In addition, IRO1 (Supplementary Note 2), which is involved in iron homeostasis 26 , and VPS21, which is involved in vacuolar trafficking 19 , affected FoG and not RAD.”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [26]
In the citing paper
“Hsp90 and calcineurin are well known to affect fungal drug responses, including the cidality of azoles 26,32,42,43,70,71 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [26]
In the citing paper
“We showed earlier that iron metabolism is involved in regulating susceptibility to fluconazole, since addition of the iron chelator doxycycline to fluconazole-treated Candida albicans and S. cerevisiae cells reduces or even completely abolishes tolerance (7, 27).”
From Mitochondrial Cochaperone Mge1 Is Involved in Regulating Susceptibility to Fluconazole in Saccharomyces cerevisiae and Candida Species (2017) · cites this paper as [7]
In the citing paper
“The tetracycline antibiotic, doxycycline, has been shown to also drastically increase the susceptibility of C. albicans to fluconazole, due to the ability of doxycycline to chelate iron and cause iron starvation in C. albicans (Fiori and Van Dijck, 2012).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Fiori and Van Dijck, 2012
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 1×
“Tetracyclines are antibacterial drugs that prevent the association of acylated tRNAs with the ribosome, therefore inhibiting translation (9).”
BackgroundEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Infections by Candida albicans have been on the rise in the past decades, mostly due to changes in the clinical practice, such as the increased use of immunosuppressants and broad-spectrum antibacterial agents (26, 29, 47).”
BackgroundSherman, F. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)50954-x · Cited by 4,121 · cited 1×
“and uracil at appropriate concentrations (59).”
[1] Getting started with yeast
Sherman, F. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)94004-v · Cited by 4,067
Gietz, R. D., & Akio, S. (1988) · Gene · doi:10.1016/0378-1119(88)90185-0 · Cited by 2,884
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481 · cited 2×
“sidered informative for the establishment of interactions (22, 41).”
BackgroundIsogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373 · cited 1×
“Calcineurin is inactive under normal conditions, being activated only in the presence of certain external cues (52).”
BackgroundGillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,251 · cited 14×
“For overexpression studies in C. albicans, CaERG11 was amplified from genomic DNA of strain SC5314 using primers CaERG11s (5=-CCCAAGCTTATGGCTATTGTTGAAACTGTCA-3”
ResultInfluential
Research works printed but not linked: 2
- BackenAC . 2000. Evaluation of the CaMAL2 promoter for regulated expression of genes in Candida albicans. Yeast 16:1121–1129. · DOI · Paper page
- LewisRE. 2009. Overview of the changing epidemiology of candidemia. Curr. Med. Res. Opin. 25:1732–1740.
Cited by
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Geddes‐McAlister, J., & Shapiro, R. S. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159
Liu, S., Hou, Y., Chen, X., Gao, Y., Li, H., & Sun, S. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.12.009 · Cited by 164
Iron at the Centre of Candida albicans Interactions
Fourie, R., Kuloyo, O. O., Mochochoko, B. M., Albertyn, J., & Pohl, C. H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00185 · Cited by 118
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118
Elevated catalase expression in a fungal pathogen is a double-edged sword of iron
Pradhan, A., Herrero-de-Dios, C., Belmonte, R., Budge, S., Lopez Garcia, A., Kolmogorova, A., Lee, K. K., Martin, B. D., Ribeiro, A., Bebes, A., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006405 · Cited by 90
Singh, B. N., Upreti, D. K., Singh, B. R., Pandey, G., Verma, S., Roy, S., Naqvi, A. H., & Rawat, A. K. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03599-14 · Cited by 88
Drug repurposing strategies in the development of potential antifungal agents
Zhang, Q., Liu, F., Zeng, M., Xin, C., Zhang, J., Mao, Y., & Song, Z. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11407-7 · Cited by 82
Gerstein, A. C., Rosenberg, A., Hecht, I., & Berman, J. (2016) · Microbiology · doi:10.1099/mic.0.000295 · Cited by 63
Vu, B. G., Thomas, G. H., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.00934-19 · Cited by 59
“Previous experiments have demonstrated an unexpected synergy between doxycycline and fluconazole (19).”
BackgroundWeitz, I. S., Maoz, M., Panitz, D. Y., Eichler, S., & Segal, E. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3149-4 · Cited by 59
Eldesouky, H. E., Salama, E. A., Li, X., Hazbun, T. R., Mayhoub, A. S., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-64571-7 · Cited by 55
Savage, K. A., Parquet, M. D. C., Allan, D. S., Davidson, R. J., Holbein, B. E., Lilly, E. A., & Fidel, P. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02576-17 · Cited by 53
“DIBI and FLC were tested in a checkerboard assay in 96-well plates in a similar manner to that described by Fiori and Van Dijck (32), with the following modifications.”
BackgroundMethodInfluentialStudy of Candida albicans and its interactions with the host: A mini review
Tsai, P.-W., Chen, Y.-T., Hsu, P., & Lan, C. (2013) · Biomedicine · doi:10.1016/j.biomed.2012.12.004 · Cited by 71
“[129] Fiori A, Van Dijck P.”
Jia, W., Zhang, H., Li, C., Li, G., Liu, X., & Wei, J. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0728-1 · Cited by 52
“albicans biofilm killing could be synergistically enhanced when it was employed in a combination with some antibiotics or immunosuppressants [7–14].”
Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
Antić, D. R., Parčina, M., Gobin, I., & Didović, M. P. (2022) · Antibiotics · doi:10.3390/antibiotics11081105 · Cited by 60
“, the benefit of using iron chelators in conjunction with most tetracyclines [101,102].”
BackgroundSeman, B. G., Moore, J. L., Scherer, A. K., Blair, B. A., Manandhar, S., Jones, J. M., & Wheeler, R. T. (2018) · Infection and Immunity · doi:10.1128/iai.00415-18 · Cited by 46
“expected on the basis of previously published work (55), the addition of approximately equimolar levels of ferric chloride eliminated this inhibition without blocking the ability of DOX to allow the NRG1OEX strain to make filaments.”
BackgroundSuchodolski, J., Muraszko, J., Korba, A., Bernat, P., & Krasowska, A. (2019) · Yeast · doi:10.1002/yea.3455 · Cited by 47
Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?
Demuyser, L., & Dijck, P. V. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.02.002 · Cited by 46
Li, X., Yu, C., Huang, X., & Sun, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168936 · Cited by 44
Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Gao, Y., Zhang, C., Lu, C., Liu, P., Li, Y., Li, H., & Sun, S. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12048 · Cited by 39
Ghio, A. J., Soukup, J. M., Dailey, L. A., & Madden, M. C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.007 · Cited by 39
Gu, W., Yu, Q., Yu, C., & Sun, S. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.11.011 · Cited by 39
Eldesouky, H. E., Lanman, N. A., Hazbun, T. R., & Seleem, M. N. (2020) · Virulence · doi:10.1080/21505594.2020.1838741 · Cited by 37
“Notably, iron homeostasis has been regarded as a potential target for other azole chemosensitizing agents such as doxycycline and lactoferrin [65,66].”
BackgroundSoberón, J. R., Sgariglia, M. A., Pastoriza, A. C., Soruco, E. M., Jäger, S. N., Labadié, G. R., Sampietro, D. A., & Vattuone, M. A. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.03.056 · Cited by 38
Potentiation of Azole Antifungals by 2-Adamantanamine
LaFleur, M. D., Sun, L., Lister, I., Keating, J., Nantel, A., Long, L., Ghannoum, M., North, J., Lee, R. E., Coleman, K., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-13 · Cited by 35
“Synergy with doxycycline occurred at high concentrations, which are unlikely to be clinically achievable, and was due to iron chelation (29).”
BackgroundLi, X., Zhao, Y., Huang, X., Yu, C., Yang, Y., & Sun, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00124 · Cited by 35
“7:124. doi: 10.3389/fcimb.2017.00124 Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole Xiuyun Li 1, Yuanhao Zhao 2, Xin Huang 2, Cuixiang Yu 3, Yilei Yang 2 and Shujuan Sun 2* 1 School of Pharmaceutical Sciences, Shandong University, Jinan,…”
BackgroundInfluentialChemogenomic Profiling of the Fungal Pathogen Candida albicans
Chen, Y., Mallick, J., Maqnas, A., Sun, Y., Choudhury, B. I., Côte, P., Yan, L., Ni, T.-J.-H., Li, Y., Zhang, D., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02365-17 · Cited by 29
“This complication has been particularly evident in the case of azoles (24).”
InfluentialDemuyser, L., Swinnen, E., Fiori, A., Herrera-Malaver, B., Verstrepen, K., & Van Dijck, P. (2017) · mBio · doi:10.1128/mbio.00201-17 · Cited by 33
“To reduce the background growth of the reference strain on the screening medium containing supra-minimum inhibitory concentrations (MICs) of fluconazole, we added the iron chelator doxycycline, for which we and others reported a synergistic effect with fluconazole earlier (7, 27).”
InfluentialSelf-citationde Jesus, F. P. K., Ferreiro, L., Loreto, É. S., Pilotto, M. B., Ludwig, A., Schlemmer, K. B., Tondolo, J. S. M., Zanette, R. A., Alves, S. H., & Santúrio, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02349-14 · Cited by 34
Alves, R. M. A., Kastora, S. L., Gomes-Gonçalves, A., Azevedo, N. F., Rodrigues, C. F., Silva, S. M., Demuyser, L., Dijck, P. V., Casal, M., Brown, A. J. P., et al. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0114-5 · Cited by 34
Scott, J., Sueiro-Olivares, M., Thornton, B. P., Owens, R. A., Muhamadali, H., Fortune‐Grant, R., Thomson, D. D., Thomas, R., Hollywood, K. A., Doyle, S., et al. (2020) · mBio · doi:10.1128/mbio.01985-20 · Cited by 34
Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Musioł, R., Mrozek‐Wilczkiewicz, A., & Polański, J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131218094848 · Cited by 35
Combinatorial drug approaches to tackleCandida albicansbiofilms
Cremer, K. D., Staes, I., Delattin, N., Cammue, B. P. A., Thevissen, K., & Brucker, K. D. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1056162 · Cited by 35
“Fiori and Van Dijck observed a reverse of the effect of doxycycline upon addition of iron which suggests the involvement of iron depletion in the underlying mechanism of this synergistic association [81].”
BackgroundThe role of gene copy number variation in antimicrobial resistance in human fungal pathogens
Jay, A., Jordan, D., Gerstein, A. C., & Landry, C. R. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00072-1 · Cited by 30
Antifungal adjuvants: Preserving and extending the antifungal arsenal
Butts, A., Palmer, G. E., & Rogers, P. D. (2017) · Virulence · doi:10.1080/21505594.2016.1216283 · Cited by 26
“achievable, doxycycline has been shown to enhance the activity of various azoles at much lower concentrations.(17) Azoles inhibit lanosterol demethylase, a key component of the ergosterol biosynthesis pathway.”
BackgroundAntifungal potential of eugenyl acetate against clinical isolates of Candida species
Musthafa, K. S., Hmoteh, J., Thamjarungwong, B., & Voravuthikunchai, S. P. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.07.012 · Cited by 28
Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species
Tan, J., Jiang, S., Tan, L., Shi, H., Yang, L., Sun, Y., & Wang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.649026 · Cited by 28
Hosogaya, N., Miyazaki, T., Nagi, M., Tanabe, K., Minematsu, A., Nagayoshi, Y., Yamauchi, S., Nakamura, S., Imamura, Y., Izumikawa, K., et al. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12043 · Cited by 28
Silva, L. N., de Mello, T. P., Ramos, L. S., Branquinha, M. H., & dos Santos, A. L. S. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025152412 · Cited by 29
Alternative treatment of fungal infections: Synergy with non‐antifungal agents
Rossato, L. L., dos Santos, M. C., Vitale, R. G., de Hoog, S., & Ishida, K. (2020) · Mycoses · doi:10.1111/myc.13203 · Cited by 30
Gao, Y., Li, H., Liu, S., Zhang, X., & Sun, S. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.072421-0 · Cited by 28
Molecular genetic techniques for gene manipulation inCandida albicans
Xu, Q., Yan, L., Lv, Q., Zhou, M., Sui, X., Cao, Y., & Jiang, Y. (2014) · Virulence · doi:10.4161/viru.28893 · Cited by 28
“albicans.(58) Otherwise, this system requires more transformation steps to disrupt two copies of the target gene than the “Tet-Off” system does.”
BackgroundIdentification and characterization of mediators of fluconazole tolerance in Candida albicans
Delarze, E., Brandt, L., Trachsel, E., Patxot, M., Pralong, C., Maranzano, F., Chauvel, M., Legrand, M., Znaidi, S., Bougnoux, M.-E., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.591140 · Cited by 25
Effect of iron chelation on anti-pseudomonal activity of doxycycline
Faure, M., Cilibrizzi, A., Abbate, V., Bruce, K., & Hider, R. C. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106438 · Cited by 28
Almeida‐Paes, R., de Andrade, I. B., Ramos, M. L. M., Rodrigues, M., Alves, V., Bernardes‐Engemann, A. R., & Frasés, S. (2021) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760210207 · Cited by 25
“(47) The mechanism of action of this synergistic effect appears to be related to an interference with iron homeostasis.(48) Further studies of synergism between the drugs present in the MMV COVID Box and the currently used antifungal drugs may reveal new molecules with potential antifungal activity.”
BackgroundLee, M., Hung, S.-H., Huang, M.-C., Tsai, T., & Chen, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178493 · Cited by 26
Copper potentiates azole antifungal activity in a way that does not involve complex formation
Hunsaker, E. W., & Franz, K. J. (2019) · Dalton Transactions · doi:10.1039/c9dt00642g · Cited by 29
Forging New Antibiotic Combinations under Iron-Limiting Conditions
Chan, D. C. K., Guo, I., & Burrows, L. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01909-19 · Cited by 25
Role of Catalase Overproduction in Drug Resistance and Virulence in Candida Albicans
Román, E., Prieto, D., Martín, R. J., Correia, I., Arango, A. C. M., Alonso‐Monge, R., Zaragoza, Ó., & Plá, J. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0067 · Cited by 26
New diphenylphosphane derivatives of ketoconazole are promising antifungal agents
de Almeida, R. F. M., Santos, F. C., Marycz, K., Alicka, M., Krasowska, A., Suchodolski, J., Panek, J. J., Jezierska, A., & Starosta, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-52525-7 · Cited by 26
Soberón, J. R., Sgariglia, M. A., Torrez, J. A. C., Aguilar, F. A., Pero, E. J. I., Sampietro, D. A., de Luco, J. F., & Labadié, G. R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05174 · Cited by 23
“albicans 12–99), were considered to be 8 μg/mL and 256 μg/mL respectively (referred to as MIC-0FLU) for calculation purposes, a criterion reported by other authors [26].”
MethodCandida albicans reprioritizes metal handling during fluconazole stress
Hunsaker, E. W., & Franz, K. J. (2019) · Metallomics · doi:10.1039/c9mt00228f · Cited by 22
Asthma as a disruption in iron homeostasis
Ghio, A. J. (2016) · BioMetals · doi:10.1007/s10534-016-9948-y · Cited by 23
Barceló, S., Peralta, M. A., Calise, M., Finck, S., Ortega, G., Diez, R. A., Cabrera, J. L., & Pérez, C. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.05.001 · Cited by 21
The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_29 · Cited by 24
Van Hauwenhuyse, F., Fiori, A., & Van Dijck, P. (2014) · Eukaryotic Cell · doi:10.1128/ec.00096-14 · Cited by 20
“5-fold higher expression than the control strain) (42), but as shown in Fig.”
BackgroundSelf-citationThe intricate link between iron, mitochondria and azoles in Candida species
Genechten, W. V., Vergauwen, R., & Dijck, P. V. (2023) · FEBS Journal · doi:10.1111/febs.16977 · Cited by 25
Hacıoğlu, M., Tan, A. S. B., Döşler, S., İnan, N., & Ötük, G. (2018) · PeerJ · doi:10.7717/peerj.5263 · Cited by 21
Gao, L., Sun, Y., Yuan, M., Li, M., & Zeng, T. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00290-20 · Cited by 20
Beswick, E., Amich, J., & Gago, S. (2020) · Pathogens · doi:10.3390/pathogens9080639 · Cited by 20
Pseudomonas Synergizes with Fluconazole against Candida during Treatment of Polymicrobial Infection
Hattab, S., Dagher, A.-M., & Wheeler, R. T. (2022) · Infection and Immunity · doi:10.1128/iai.00626-21 · Cited by 22
Lown, L., Peters, B. M., Walraven, C. J., Noverr, M. C., & Lee, S. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159225 · Cited by 19
“a widely used broad-spectrum antibiotic [32] and has demonstrated in vitro antifungal activity in combination with fluconazole [23].”
BackgroundHierro e infección fúngica invasiva
Álvarez, F., Fernández‐Ruiz, M., & Aguado, J. M. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.04.002 · Cited by 25
Gaspar‐Cordeiro, A., Amaral, C., Pobre, V., Antunes, W., Petronilho, A., Paixão, P., Matos, A., & Pimentel, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.920574 · Cited by 18
Hooper, R. W., Ashcraft, D. S., & Pankey, G. A. (2018) · Medical Mycology · doi:10.1093/mmy/myy008 · Cited by 20
Rashid, S., Correia-Mesquita, T. O., Godoy, P., Omran, R. P., & Whiteway, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.764711 · Cited by 15
Soberón, J. R., Lizárraga, E., Sgariglia, M. A., Juárez, M. B. C., Sampietro, D. A., Altabef, A. B., Catalán, C. A. N., & Vattuone, M. A. (2015) · Antonie van Leeuwenhoek · doi:10.1007/s10482-015-0559-3 · Cited by 15
Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole
Demuyser, L., Dyck, K. V., Timmermans, B., & Dijck, P. V. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01998-18 · Cited by 15
“The interaction between fluconazole and sortins was determined by checkerboard analysis, generally as described previously (31).”
BackgroundMethodXiong, E. H., Zhang, X., Yan, H., Ward, H. N., Lin, Z., Wong, C. J., Fu, C., Gingras, A., Noble, S. M., Robbins, N., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114601 · Cited by 12
“68 As a result, there may be clusters of genes identified as hits in our screen that represent synthetic interactions between the repressed target gene and DOX rather than repression of the gene alone.”
BackgroundSztafrowski, D., Suchodolski, J., Muraszko, J., Sigler, K., & Krasowska, A. (2019) · Folia Microbiologica · doi:10.1007/s12223-019-00686-3 · Cited by 12
Prentice, S., Webb, E. L., Dockrell, H. M., Kaleebu, P., Elliott, A. M., & Cose, S. (2015) · Trials · doi:10.1186/s13063-015-0682-5 · Cited by 13
“Iron supply is critical for the virulence of most pathogens [36], with plasma hypoferraemia profoundly inhibiting the growth of bacteria [37,38], viruses [39], protozoa [40-43] and fungi [44,45].”
BackgroundOral Candida in Patients with Fixed Orthodontic Appliance: In Vitro Combination Therapy
Alhamadi, W. W., Al‐Saigh, R., Aldabagh, N. N., & Al‐Humadi, H. (2017) · BioMed Research International · doi:10.1155/2017/1802875 · Cited by 12
“Additionally, DOX appears to have a major impact on prevention of azole tolerance [13].”
BackgroundVenturini, T. P., Al‐Hatmi, A. M. S., Rossato, L. L., de Azevedo, M. I., Keller, J. T., Weiblen, C., Santúrio, J. M., & Alves, S. H. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.017 · Cited by 13
Liu, Y., Wang, W., Yan, H., Wang, D., Zhang, M., & Sun, S. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0076 · Cited by 12
Dümig, M., & Krappmann, S. (2014) · Fungal biology · doi:10.1007/978-3-319-10503-1_10 · Cited by 9
Zhou, W., Yin, Y., Smith, E. W., Chou, J., Shumate, J., Scampavia, L. D., Spicer, T., Carpino, N., & French, J. B. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00238 · Cited by 8
Bortolami, M., Pandolfi, F., Messore, A., Rocco, D., Feroci, M., Santo, R. D., Vita, D. D., Costi, R., Cascarino, P., Simonetti, G., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128087 · Cited by 11
Caspofungin binding to iron compromises its antifungal efficacy against Candida albicans
Pedras, A., Malta-Luís, C., Lima, L. M. P., Mil‐Homens, D., Amaral, C., Duarte, A. G., Antunes, W., Gaspar‐Cordeiro, A., Louro, R. O., Lamosa, P., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08834-x · Cited by 7
“The assays were performed in SC citrate medium using 96-well fl at bottom plates, according totheCLSIstandard methodsM27-A3and M38foryeast and fi lamentous fungi, respectively 54,55 , as described in 56,57 , with minor modi fi cations.”
Mechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 11
Brennan-Krohn, T., Friar, L., Ditelberg, S., & Kirby, J. E. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00268-21 · Cited by 8
Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans
Hameed, S., Hans, S., Singh, S., & Fatima, Z. (2019) · Current Drug Discovery Technologies · doi:10.2174/1570163816666190227231437 · Cited by 7
de Abreu, M. H., Bitencourt, T. A., Franco, M. E., Moreli, I. S., Cantelli, B. A. M., Komoto, T. T., Marins, M., & Fachin, A. L. (2020) · Mycoses · doi:10.1111/myc.13088 · Cited by 6
The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_29-1 · Cited by 7
DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases
Chen, S., Gao, N., Li, C., Zhai, F., Jiang, X., Zhang, P., Guan, J., Li, K., Xiang, R., & Ling, G. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00296 · Cited by 5
Gao, Y., Zhang, Z., Lun, Z., Gong, L., Xu, A., & Li, X. (2022) · Microbial Drug Resistance · doi:10.1089/mdr.2021.0301 · Cited by 5
da Silva, C. R., Silveira, M. J. C. B., Soares, G. C., de Andrade, C. R., Cabral, V. P. D. F., Sá, L. G. D. A. V., Rodrigues, D. S., Moreira, L. E. A., Barbosa, A. D., da Silva, L. J., et al. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001759 · Cited by 4
Genechten, W. V., Holtappels, M., Jonge, M. D., Vergauwen, R., Cornips, G., & Dijck, P. V. (2026) · mBio · doi:10.1128/mbio.00416-26 · Cited by 2
“That iron availability is tightly linked to FLC tolerance was already reported by our laboratory, as we previously showed that a combination treatment of doxycycline, which has iron chelating properties, renders fluconazole fungicidal (7).”
InfluentialDoxycycline in STI Prophylaxis—A Literature Review
Załęski, A., Sapuła, M., Lembas, A., & Wiercińska‐Drapało, A. (2023) · Venereology · doi:10.3390/venereology3010001 · Cited by 4
“There is evidence suggesting that doxycycline can have antifungal activity when used in conjunction with classical antifungals [31–33].”
BackgroundPohl, C. H. (2022) · Infection and Immunity · doi:10.1128/iai.00057-22 · Cited by 3
“The resultant iron limitation may influence the susceptibility to fluconazole (24, 25), by altering membrane fluidity and permeability, leading to increased susceptibility to antifungal agents or by suppressing the calcineurin stress response pathway, leading to increased sensitivity to membrane stress, such as those…”
BackgroundDoxycycline induces SLT2 phosphorylation in Candida glabrata
Almshawit, H., & Macreadie, I. G. (2017) · International Journal of Clinical & Medical Microbiology · doi:10.15344/2456-4028/2017/122 · Cited by 1
“Doxycycline is an iron chelator leading to depletion of intracellular iron [8].”
BackgroundMethodInfluentialDonkor, M. N., Kuubabongnaa, N., & Donkor, A.-M. (2021) · Journal of Applied Biotechnology & Bioengineering · doi:10.15406/jabb.2021.08.00251 · Cited by 1
Sharma, A., Homayoon, A., Weyler, M., Frazer, C., Ramírez-Zavala, B., Morschhäuser, J., & Bennett, R. J. (2025) · mBio · doi:10.1128/mbio.00581-25 · Cited by 1
“The current study further highlights how strain-specific differences can have striking effects on TF-induced phenotypes.”
Hannan, F. K. A., & Muhammad, U. A. (2014) · African Journal of Microbiology Research · doi:10.5897/ajmr2013.6168
Vasicek, E. M. (2013) · doi:10.21007/etd.cghs.2013.0335
“Further emphasis for targeting the iron uptake system in combination with antifungal treatment was provided by the observation that doxycycline acts synergistically with fluconazole (266).”
Lai, Y. (2016) · The Sydney eScholarship Repository (The University of Sydney)
Role of Mitochondria in Fungal Drug Resistance
Pasrija, R., & Kundu, D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9449-3_8
Metadata
- Authors
- Fiori, A., & Van Dijck, P.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Department of Molecular Microbiology, Flanders Institute for Biotechnology (VIB), Katholieke Universiteit Leuven, Leuven, Belgium
- ORCID
- Fiori, Alessandro
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-07
- Volume
- 56
- Issue
- 7
- Pages
- 3785-3796
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3393430
- OpenAlex
- W2076426605
- Cited by
- 112
- References
- 65
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 13 · 2018: 8 · 2017: 13 · 2016: 9 · 2015: 6 · 2014: 10 · 2013: 7
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- doxycycline, fluconazole, Candida albicans, drug synergy, iron homeostasis, iron chelation, fungicidal activity, antifungal resistance, calcineurin, ERG11, checkerboard assay
- MeSH terms
- Candida albicans, Cytochrome P-450 Enzyme System, Doxycycline, Drug Synergism, Homeostasis, Iron, Microbial Sensitivity Tests, Saccharomyces cerevisiae, Fluconazole, Saccharomyces cerevisiae Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.